ADARx Pharmaceuticals, Inc. (ADRX) vs Tyra Biosciences, Inc. (TYRA)

ADARx Pharmaceuticals, Inc. ADRX 13.20 −0.68%
Tyra Biosciences, Inc. TYRA 21.09 +0.96%

ADARx Pharmaceuticals, Inc. and Tyra Biosciences, Inc. are both Biotechnology companies. ADARx Pharmaceuticals, Inc. and Tyra Biosciences, Inc. are of similar size ($1.5B and $1.4B).

Metric	ADRX	TYRA	Biotechnology median
P/E	—	n/m	10.60
P/S	—	n/m	9.40
P/B	—	3.94	2.13
Price to free cash flow	—	n/m	25.18
EV/EBITDA	—	n/m	0.66
EV/Sales	—	n/m	9.02
Earnings yield	—	(11.38%)	(32.88%)
Free cash flow yield	—	(7.90%)	(23.13%)

Metric	ADRX	TYRA	Biotechnology median
Gross margin	—	0.00%	68.51%
Operating margin	—	0.00%	0.00%
Net margin	—	0.00%	0.00%
Free cash flow margin	—	0.00%	0.00%
Return on equity	—	(45.31%)	(51.96%)
Return on assets	—	(42.15%)	(46.06%)
Return on invested capital	—	0.00%	0.00%

Metric	ADRX	TYRA	Biotechnology median
Revenue growth (TTM)	—	—	6.76%
EPS growth (last fiscal year)	—	(33.11%)	29.88%
Revenue growth, 5-year CAGR	—	—	9.75%
Net income growth, 5-year CAGR	—	0.00%	0.00%

Metric	ADRX	TYRA	Biotechnology median
Debt to equity	—	0.00	0.00
Current ratio	—	14.91	4.97
Net debt to EBITDA	—	1.94	1.01

Metric	ADRX	TYRA	Biotechnology median
Dividend yield	—	—	0.41%
Payout ratio	—	—	—

Metric	ADRX	TYRA	Biotechnology median
Market cap	1.47b	1.44b	161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack